We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Lays Out Final Guidance for Buprenorphine Pumps, Injections
FDA Lays Out Final Guidance for Buprenorphine Pumps, Injections
Sponsors may not have to conduct new efficacy trials for the anti-opioid treatment buprenorphine injections or implants if there are existing data for similar products under a final guidance issued Wednesday.